167 related articles for article (PubMed ID: 28054649)
1. Ameloblastin induces tumor suppressive phenotype and enhances chemosensitivity to doxorubicin via Src-Stat3 inactivation in osteosarcoma.
Ando T; Kudo Y; Iizuka S; Tsunematsu T; Umehara H; Shrestha M; Matsuo T; Kubo T; Shimose S; Arihiro K; Ogawa I; Ochi M; Takata T
Sci Rep; 2017 Jan; 7():40187. PubMed ID: 28054649
[TBL] [Abstract][Full Text] [Related]
2. Ameloblastin regulates osteogenic differentiation by inhibiting Src kinase via cross talk between integrin beta1 and CD63.
Iizuka S; Kudo Y; Yoshida M; Tsunematsu T; Yoshiko Y; Uchida T; Ogawa I; Miyauchi M; Takata T
Mol Cell Biol; 2011 Feb; 31(4):783-92. PubMed ID: 21149578
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells promote osteosarcoma cell survival and drug resistance through activation of STAT3.
Tu B; Zhu J; Liu S; Wang L; Fan Q; Hao Y; Fan C; Tang TT
Oncotarget; 2016 Jul; 7(30):48296-48308. PubMed ID: 27340780
[TBL] [Abstract][Full Text] [Related]
4. Critical role of heparin binding domains of ameloblastin for dental epithelium cell adhesion and ameloblastoma proliferation.
Sonoda A; Iwamoto T; Nakamura T; Fukumoto E; Yoshizaki K; Yamada A; Arakaki M; Harada H; Nonaka K; Nakamura S; Yamada Y; Fukumoto S
J Biol Chem; 2009 Oct; 284(40):27176-84. PubMed ID: 19648121
[TBL] [Abstract][Full Text] [Related]
5. The ameloblastin extracellular matrix molecule enhances bone fracture resistance and promotes rapid bone fracture healing.
Lu X; Li W; Fukumoto S; Yamada Y; Evans CA; Diekwisch T; Luan X
Matrix Biol; 2016; 52-54():113-126. PubMed ID: 26899203
[TBL] [Abstract][Full Text] [Related]
6. Targeted inhibition of T-cell factor activity promotes syndecan-2 expression and sensitization to doxorubicin in osteosarcoma cells and bone tumors in mice.
Dieudonné FX; Marion A; Marie PJ; Modrowski D
J Bone Miner Res; 2012 Oct; 27(10):2118-29. PubMed ID: 22550000
[TBL] [Abstract][Full Text] [Related]
7. Notoginsenoside R1 counteracts mesenchymal stem cell-evoked oncogenesis and doxorubicin resistance in osteosarcoma cells by blocking IL-6 secretion-induced JAK2/STAT3 signaling.
Lu M; Xie K; Lu X; Lu L; Shi Y; Tang Y
Invest New Drugs; 2021 Apr; 39(2):416-425. PubMed ID: 33128383
[TBL] [Abstract][Full Text] [Related]
8. Alternol, a natural compound, exerts an anti-tumour effect on osteosarcoma by modulating of STAT3 and ROS/MAPK signalling pathways.
Zuo D; Zhou Z; Wang H; Zhang T; Zang J; Yin F; Sun W; Chen J; Duan L; Xu J; Wang Z; Wang C; Lin B; Fu Z; Liao Y; Li S; Sun M; Hua Y; Zheng L; Cai Z
J Cell Mol Med; 2017 Feb; 21(2):208-221. PubMed ID: 27624867
[TBL] [Abstract][Full Text] [Related]
9. Leukemia inhibitory factor promotes tumor growth and metastasis in human osteosarcoma via activating STAT3.
Liu B; Lu Y; Li J; Liu Y; Liu J; Wang W
APMIS; 2015 Oct; 123(10):837-46. PubMed ID: 26271643
[TBL] [Abstract][Full Text] [Related]
10. G721-0282 inhibits cell growth and induces apoptosis in human osteosarcoma through down-regulation of the STAT3 pathway.
Park KR; Yun HM; Hong JT
Int J Biol Sci; 2020; 16(2):330-341. PubMed ID: 31929760
[TBL] [Abstract][Full Text] [Related]
11. Antiproliferative and antimigratory effects of doxorubicin in human osteosarcoma cells exposed to extracellular matrix.
Harisi R; Dudás J; Tímár F; Pogány G; Paku S; Tímár J; Kovalszky I; Szendroi M; Jeney A
Anticancer Res; 2005; 25(2A):805-13. PubMed ID: 15868912
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of neuropilin-1 suppresses invasion, angiogenesis, and increases the chemosensitivity to doxorubicin in osteosarcoma cells - an in vitro study.
Yue B; Ma JF; Yao G; Yang MD; Cheng H; Liu GY
Eur Rev Med Pharmacol Sci; 2014; 18(12):1735-41. PubMed ID: 24992616
[TBL] [Abstract][Full Text] [Related]
13. IGF1R-targeted therapy and its enhancement of doxorubicin chemosensitivity in human osteosarcoma cell lines.
Luk F; Yu Y; Walsh WR; Yang JL
Cancer Invest; 2011 Oct; 29(8):521-32. PubMed ID: 21843050
[TBL] [Abstract][Full Text] [Related]
14. Pterostilbene exerts antitumor activity against human osteosarcoma cells by inhibiting the JAK2/STAT3 signaling pathway.
Liu Y; Wang L; Wu Y; Lv C; Li X; Cao X; Yang M; Feng D; Luo Z
Toxicology; 2013 Feb; 304():120-31. PubMed ID: 23313376
[TBL] [Abstract][Full Text] [Related]
15. Sensitizing osteosarcoma stem cells to doxorubicin-induced apoptosis through retention of doxorubicin and modulation of apoptotic-related proteins.
Gonçalves C; Martins-Neves SR; Paiva-Oliveira D; Oliveira VE; Fontes-Ribeiro C; Gomes CM
Life Sci; 2015 Jun; 130():47-56. PubMed ID: 25818183
[TBL] [Abstract][Full Text] [Related]
16. SiRNA-mediated silencing of beta-catenin suppresses invasion and chemosensitivity to doxorubicin in MG-63 osteosarcoma cells.
Zhang F; Chen A; Chen J; Yu T; Guo F
Asian Pac J Cancer Prev; 2011; 12(1):239-45. PubMed ID: 21517265
[TBL] [Abstract][Full Text] [Related]
17. Ameloblastin as a putative marker of specific bone compartments.
Jacques J; Hotton D; Asselin A; De la Dure-Molla M; Coudert AE; Isaac J; Berdal A
Connect Tissue Res; 2014 Aug; 55 Suppl 1():117-20. PubMed ID: 25158194
[TBL] [Abstract][Full Text] [Related]
18. Synergistic Effects of a Smac Mimetic with Doxorubicin Against Human Osteosarcoma.
Kamata E; Kawamoto T; Ueha T; Hara H; Fukase N; Minoda M; Morishita M; Takemori T; Fujiwara S; Nishida K; Kuroda R; Kurosaka M; Akisue T
Anticancer Res; 2017 Nov; 37(11):6097-6106. PubMed ID: 29061790
[TBL] [Abstract][Full Text] [Related]
19. An Evolutionarily Conserved Helix Mediates Ameloblastin-Cell Interaction.
Su J; Bapat RA; Visakan G; Moradian-Oldak J
J Dent Res; 2020 Aug; 99(9):1072-1081. PubMed ID: 32401578
[TBL] [Abstract][Full Text] [Related]
20. Alantolactone induces apoptosis, promotes STAT3 glutathionylation and enhances chemosensitivity of A549 lung adenocarcinoma cells to doxorubicin via oxidative stress.
Maryam A; Mehmood T; Zhang H; Li Y; Khan M; Ma T
Sci Rep; 2017 Jul; 7(1):6242. PubMed ID: 28740138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
